Fuyun Ji

587 total citations
19 papers, 329 citations indexed

About

Fuyun Ji is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Fuyun Ji has authored 19 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Fuyun Ji's work include Mitochondrial Function and Pathology (5 papers), RNA modifications and cancer (5 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). Fuyun Ji is often cited by papers focused on Mitochondrial Function and Pathology (5 papers), RNA modifications and cancer (5 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). Fuyun Ji collaborates with scholars based in China. Fuyun Ji's co-authors include Guisheng Qian, Guoming Wu, Pin Qian, Jin Li, Peipei Li, Lijie Ma, Faguang Jin, Jianping Xu, Yongjuan Zhang and Ruijie Zhang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Free Radical Biology and Medicine.

In The Last Decade

Fuyun Ji

19 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fuyun Ji China 14 226 88 63 50 31 19 329
Yueh‐Te Lin Taiwan 7 326 1.4× 110 1.3× 44 0.7× 82 1.6× 62 2.0× 10 459
Yijuan Xin China 13 330 1.5× 195 2.2× 32 0.5× 49 1.0× 15 0.5× 25 412
Wei-Wen Jiang United States 6 288 1.3× 96 1.1× 33 0.5× 66 1.3× 11 0.4× 6 461
Richard Kirkman United States 11 221 1.0× 46 0.5× 58 0.9× 46 0.9× 57 1.8× 18 379
Jéssica Rodrigues Plaça Brazil 14 323 1.4× 206 2.3× 39 0.6× 50 1.0× 75 2.4× 28 495
Haicheng Tang China 12 274 1.2× 176 2.0× 50 0.8× 60 1.2× 53 1.7× 25 404
Weimin Ding China 10 171 0.8× 63 0.7× 52 0.8× 100 2.0× 49 1.6× 25 307
Eduardo Caleiras Spain 11 157 0.7× 79 0.9× 66 1.0× 53 1.1× 40 1.3× 37 291
Amirtharaj Francis India 12 179 0.8× 141 1.6× 46 0.7× 110 2.2× 82 2.6× 20 379
Ömer An Singapore 16 628 2.8× 210 2.4× 31 0.5× 61 1.2× 55 1.8× 30 740

Countries citing papers authored by Fuyun Ji

Since Specialization
Citations

This map shows the geographic impact of Fuyun Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuyun Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuyun Ji more than expected).

Fields of papers citing papers by Fuyun Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuyun Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuyun Ji. The network helps show where Fuyun Ji may publish in the future.

Co-authorship network of co-authors of Fuyun Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Fuyun Ji. A scholar is included among the top collaborators of Fuyun Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuyun Ji. Fuyun Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hong, Xia, Cheng Wang, Yi‐Long Wu, et al.. (2025). Metformin inhibits the growth of SCLC cells by inducing autophagy and apoptosis via the suppression of EGFR and AKT signalling. Scientific Reports. 15(1). 6081–6081. 3 indexed citations
3.
Wu, Yi, Xianhui Wang, Xihua Li, et al.. (2021). Common mtDNA variations at C5178a and A249d/T6392C/G10310A decrease the risk of severe COVID-19 in a Han Chinese population from Central China. Military Medical Research. 8(1). 15 indexed citations
4.
Wang, Xianhui, Cheng Wang, Yi Wu, et al.. (2021). Expression signature, prognosis value and immune characteristics of cathepsin F in non-small cell lung cancer identified by bioinformatics assessment. BMC Pulmonary Medicine. 21(1). 13 indexed citations
5.
Wu, Yi, Peng Zhang, Xiao‐Kang Li, et al.. (2020). ZNF300 promotes chemoresistance and aggressive behaviour in non‐small‐cell lung cancer. Cell Proliferation. 53(11). e12924–e12924. 13 indexed citations
6.
Xu, Zhi, Guoming Wu, Qi Li, et al.. (2018). Predictive Value of Combined LIPS and ANG-2 Level in Critically Ill Patients with ARDS Risk Factors. Mediators of Inflammation. 2018. 1–10. 19 indexed citations
7.
Qian, Pin, Wenhong Gao, Xiaoxiao Dong, et al.. (2017). Tumor angiogenesis of SCLC inhibited by decreased expression of FMOD via downregulating angiogenic factors of endothelial cells. Biomedicine & Pharmacotherapy. 87. 539–547. 28 indexed citations
8.
Zhang, Ruijie, Lihua Xie, Chun Liu, et al.. (2017). Contactin-1: a promising progression biomarker and therapeutic target of carcinoma. Minerva Medica. 108(2). 193–195. 4 indexed citations
9.
Zhang, Ruijie, Shenghua Sun, Fuyun Ji, et al.. (2017). CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway. Cellular Physiology and Biochemistry. 43(2). 465–480. 28 indexed citations
10.
Qian, Pin, Ruijie Zhang, Qi Li, et al.. (2016). The breast cancer susceptibility-related polymorphisms at the TOX3/LOC643714 locus associated with lung cancer risk in a Han Chinese population. Oncotarget. 7(37). 59742–59753. 11 indexed citations
11.
Zhang, Ruijie, Wei Yao, Pin Qian, et al.. (2015). Increased sensitivity of human lung adenocarcinoma cells to cisplatin associated with downregulated contactin-1. Biomedicine & Pharmacotherapy. 71. 172–184. 17 indexed citations
12.
Li, Fang, Zhi Xu, Guansong Wang, et al.. (2014). Directed Evolution of an LBP/CD14 Inhibitory Peptide and Its Anti-Endotoxin Activity. PLoS ONE. 9(7). e101406–e101406. 18 indexed citations
13.
Li, Peipei, Lijie Ma, Yongjuan Zhang, Fuyun Ji, & Faguang Jin. (2013). MicroRNA-137 down-regulates KIT and inhibits small cell lung cancer cell proliferation. Biomedicine & Pharmacotherapy. 68(1). 7–12. 33 indexed citations
14.
Wu, Guoming, Haidong Li, Pin Qian, et al.. (2013). Promoter Methylation Profiles between Human Lung Adenocarcinoma Multidrug Resistant A549/Cisplatin (A549/DDP) Cells and Its Progenitor A549 Cells. Biological and Pharmaceutical Bulletin. 36(8). 1310–1316. 24 indexed citations
15.
Wang, Changzheng, Guisheng Qian, Guoming Wu, et al.. (2012). Role of mtDNA haplogroups in COPD susceptibility in a southwestern Han Chinese population. Free Radical Biology and Medicine. 53(3). 473–481. 20 indexed citations
16.
Qian, Pin, Guisheng Qian, Changzheng Wang, et al.. (2012). Association of Mitochondrial DNA Variations with Lung Cancer Risk in a Han Chinese Population from Southwestern China. PLoS ONE. 7(2). e31322–e31322. 37 indexed citations
17.
Ji, Fuyun, et al.. (2011). MtDNA haplogroups M7 and B in southwestern Han Chinese at risk for acute mountain sickness. Mitochondrion. 11(4). 553–558. 23 indexed citations
18.
Wen, Quan, Yide Hu, Fuyun Ji, & Guisheng Qian. (2011). Mitochondrial DNA alterations of peripheral lymphocytes in acute lymphoblastic leukemia patients undergoing total body irradiation therapy. Radiation Oncology. 6(1). 133–133. 17 indexed citations
19.
Li, Shujun, Hai Yun Shi, Fuyun Ji, et al.. (2010). The Human Lung Cancer Drug Resistance-Related Gene BC006151 Regulates Chemosensitivity in H446/CDDP Cells. Biological and Pharmaceutical Bulletin. 33(8). 1285–1290. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026